When heart muscle gets damaged, the result is often permanent. Unlike other muscles in the body, the heart has long been ...

A former college track athlete and mother of five hopes her story might save lives and inspire others to listen to their ...

CorWave said the results mark the final stage of CorWave’s preclinical development, paving the way for a first-in-human study ...

At today's Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) in ...

Since the LVAD has not been approved by the FDA for use with deaf patients, only a few individuals in this population have received one. The mechanical heart pump uses loud audio alarms to notify ...

Pulsatile volume displacement pumps have evolved to continuous ... Often patients supported with an LVAD are the very best patients undergoing heart transplantation due to ability to exercise ...

Montréal-based medtech startup Puzzle Medical Devices has raised $43 million in a second Series A round to complete a clinical study of its heart pump for patients experiencing heart failure.

CorWave is developing an implantable LVAD (Left Ventricular Assist ... flow rates similar to those of a healthy heart. Ultimately, CorWave's membrane pump technology is expected to reduce the ...

or LVAD. This mechanical pump supports the heart by helping it move blood through the body. It also gives the heart a chance to rest. The scientists measured cell renewal using an unusual tool ...

The CorWave device operated in pulsatile mode, synchronizing with the native heart ... LVAD (Left Ventricular Assist Device) driven by its proprietary breakthrough wave membrane pump technology.